Form 4: Mind Medicine (MindMed) Inc. Director, Andreas Krebs, Acquires Stock Options
SEC Form 4 Filing
Director Andreas Krebs acquired stock options for 16,506 common shares in Mind Medicine (MindMed) Inc. on June 10, 2024.
Summary
- On June 10, 2024, Andreas Krebs, a director of Mind Medicine (MindMed) Inc., acquired stock options for 16,506 common shares.
- The exercise price of these options is $7.25.
- The options vest in monthly installments, with full vesting by June 9, 2034, or earlier if the company's annual meeting occurs before the first anniversary of the grant date.
- Following the transaction, Krebs directly owns 16,506 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing regarding stock option grants, which is neutral in sentiment.
Industry Context
This transaction is a routine disclosure of insider activity, which is common in publicly traded companies. It provides transparency into the actions of company directors.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding director compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 06/10/2024 | Date of stock option transaction |
| 06/09/2034 | Expiration date of the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.